Navigation Links
Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis

Scott Thompson and colleagues from University of Rochester Medical Center, has found from review of records of patients treated with corticosteroids that Corticosteroids is the most effective and useful treatment// option for Infectious mononucleosis, including severe airway compromise mononucleosis. The results of the study have been published in Achieves of Otolaryngology – Head and Neck Surgery, JAMA Journal. The researcher’s analyzed data of patients treated for Infectious mononucleosis with corticosteroids from January 1998 to March 2003. The results of the study disapproved earlier controversies over the usage of systemic corticosteroids for infectious mononucleosis.

The study review showed that Corticosteroid therapy was used in 92 patients with infectious mononucleosis of the total 206 patients with infectious mononucleosis. These results show that there was an increase in doctors treating patients with infectious mononucleosis with corticosteroids. The patients were follow up for disease prognosis during regular physician visits, inpatient admissions and during consultations.

Dr. Scott Thompson said, “Despite consistent and uniform acceptance in the medical literature that SCT in the setting of IM [infectious mononucleosis] should be reserved for patients with impending airway obstruction, corticosteroids continue to be used on a much broader scale at this tertiary care institution and this observation suggests that clinicians see value in SCT for treatment of IM beyond the classically accepted reasons. Moreover, despite previous reports of possible adverse consequences of SCT in IM, our review failed to demonstrate any such trend.”

Source: News wie
'"/>




Page: 1

Related medicine news :

1. Systemic Pre-Surgical Treatment Can Prolong Survival Of Kidney Cancer Patients
2. New Treatment Offers Hope for Systemic Sclerosis
3. Corticosteroids Safe for Bones
4. Corticosteroids Safe for Bones
5. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
6. The Effectiveness Of Inhaled Corticosteroids Studied
7. The Effectiveness Of Inhaled Corticosteroids Studied
8. Inhaled Corticosteroids Reduce Death in Patients with COPD
9. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
10. High-dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer
11. High Dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2017)... ... 27, 2017 , ... From May 21-23, hearing healthcare professionals gained a competitive ... at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , As EarQ’s ... hearing healthcare providers to help them stay ahead in the industry. At the event, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from biotech, ... 30th and 31st at The Four Seasons Hotel Boston. , The Boston ... sciences, offering exclusive access to key decision makers who influence deal making and ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of ... the healthiest seniors are located in the Midwest. With the average cost of healthcare ... people are concerned with both the quality and affordability of where they live. An ...
(Date:5/26/2017)... ... ... After raising nearly $30,000 on Kickstarter , about three-times its original ... discounted crowdfunding price on Indiegogo . , “Along with creating an anti-stress gadget ... a fidget toy to the market that was made of superior quality and wouldn’t ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled ... a new, informational blog post on insurance options. If a Bay Area patient has ... help save time and money. Visiting an in-network provider for a second opinion can ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... N.Y. , May 22, 2017  Lilac ... treatment Gene-Eden-VIR/Novirin, announces the launch of a ... English, the results of a clinical study that ... year treatment with Gene-Eden-VIR/Novirin in individuals suffering from ... to note that there are no other treatments ...
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
(Date:5/10/2017)... May 10, 2017 Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended April 1, 2017 ... $1.84 increased 666.7% compared to the prior year period ... in a significant gain, while non-GAAP diluted EPS of ... or 3.8% in constant currency terms.  Excluding the effects ...
Breaking Medicine Technology: